Connecting Innovation to Purpose
Committed to cutting-edge drug development and scientific excellence, we are dedicated to creating treatments that matter most for patients.
Advancing Oncology Treatments
At Corbus, we are dedicated to developing treatments that aim to significantly improve patient outcomes in cancer care. Our approach combines cutting-edge research with compassionate patient care, striving to transform the prognosis for individuals battling cancer.
Redefining Obesity Treatment
We approach obesity treatment with rigorous medical research, developing targeted therapies designed to make lasting health improvements achievable. Our mission is clear: to deliver solutions that enhance quality of life and provide meaningful, sustainable health benefits for patients.
Science Driven by Purpose
At Corbus, we pursue medical advancements grounded in integrity, expertise, and a genuine commitment to improving patient outcomes. Our purposeful research is not just about developing drugs- it is about making a real difference in people's lives while earning the trust of patients, healthcare professionals, and investors alike.
ESMO 2025 Update
Berlin, Germany
Oct 17 – Oct 21, 2025
On October 19, 2025 Corbus presented its Phase 1/2 clinical study of CRB-701 (SYS6002) as a poster (poster #967P) at the 2025 European Society for Medical Oncology (ESMO25) Congress held in Berlin, Germany.
Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25